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a  b  s  t  r  a  c  t
Childhood primary angiitis of the central nervous system (cPACNS) is a rare inﬂammatory
brain disease of unknown etiology. Of note, brain hemorrhage has been rarely reported in
cPACNS patients, generally associated with a delayed clinical diagnosis, or with a diagnosis
only  at necropsy. We  present the case of a boy with cPACNS that previously suffered an
ischemic stroke. At the age of 7 years and 10 months, he presented a sudden and severe
headache, vomiting and reduction in consciousness level (Glasgow coma scale 7), requiring
prompt tracheal intubation. Brain computed tomography demonstrated intraparenchymal
hematoma in the right parieto-occipital lobe and a small focus of bleeding in the right
frontal lobe, vasogenic edema, herniation of the uncus and a 10 mm deviation to the left
from the midline. C-reactive protein (9.2 mg/dL) and von Willebrand factor (vWF) antigen
(202%) were elevated. Decompressive craniotomy was performed and methylprednisolone
and cyclophosphamide were administered. One week later, the patient had left hemiparesis
without other sequelae. Importantly, motor deﬁcits have been improving progressively. Our
case  reinforces the inclusion of this vasculitis as a differential diagnosis in children and
adolescents with CNS hemorrhage.
© 2014 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Hemorragia  intracerebral  com  evoluc¸ão  favorável  em  paciente
com  angiíte  primária  do  sistema  nervoso  central  juvenil
r  e  s  u  m  oPalavras-chave:
Angiíte primária na infância
Sistema nervoso central
Angiíte primária do sistema nervoso central juvenil (APSNCJ) é uma doenc¸a inﬂamatória
cerebral rara e de etiologia desconhecida. Hemorragia cerebral tem sido raramente repor-
tada em pacientes com APSNCJ, geralmente associada com atraso diagnóstico, ou com um
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diagnóstico somente por necrópsia. Relata-se um caso de um paciente do gênero masculino
com  APSNCJ e que previamente sofreu um acidente vascular cerebral isquêmico. Aos 7 anos
e  10 meses de idade, o menino apresentou subitamente cefaleia intensa, vômitos e reduc¸ão
do nível de consciência (escala de coma de Glasgow 7), requerendo imediata intubac¸ão
traqueal. Uma tomograﬁa computadorizada cerebral demonstrou hematoma intraparen-
quimatoso no lobo parieto-occipital direito e um pequeno foco de sangramento no lobo
frontal direito, edema vasogênico, herniac¸ão do úncus e um desvio de 10 mm da linha
média para a esquerda. A proteína C-reativa (9.2 mg/dL) e o fator antígeno de von Wille-
brand (202%) estavam elevados. Foi realizada uma craniotomia descompressiva, seguida
pela administrac¸ão de metilprednisolona e ciclofosfamida. Transcorrida uma  semana, o
paciente apresentava hemiparesia esquerda, sem outras sequelas. É digno de nota que o
déﬁcit motor tem melhorado progressivamente. Nosso caso reforc¸a a inclusão dessa vas-
culite como diagnóstico diferencial em crianc¸as e adolescentes com hemorragia do sistema
nervoso central.


































asculitides are characterized by inﬂammation and necrosis
f endothelium.1 They can affect blood vessels of any organ
nd system, including the central nervous system (CNS). CNS
asculitis most often is secondary to an underlying condition,
uch as infectious, neoplastic, vascular, metabolic or inﬂam-
atory disorders, but it also can be idiopathic.2,3
Of note, childhood primary angiitis of the CNS (cPACNS) is
 rare inﬂammatory brain disease of unknown etiology that
ccurs in previously healthy children. It has protean clini-
al manifestations, such as seizures, cognitive dysfunction,
ehavior changes, headaches, neurologic deﬁcits and strokes.3
Ischemic stroke seems to occur more  often than hemor-
hagic events, which are seldom described in the literature.
s far as we  are concerned, only seven cases were reported
egarding hemorrhagic stroke and cPACNS in the literature,
ost of which had delayed clinical or necropsy diagnosis.1,4–8
We  describe a patient with cPACNS and intracerebral
emorrhage submitted to prompt drainage and immunosup-
ressive therapy with good prognosis.
ase  report
t the age of 7 years and 2 months, a boy presented
ntense headache during about 5 minutes with spontaneous
mprovement. In the next twenty-four hours, he had labial
ommissure deviation to the right side and left hemipare-
is, being hospitalized in another hospital. Laboratory exams
ere: hemoglobin 12.7 g/L, hematocrit 36%, white blood cell
ount 10,300/mm3 (neutrophils 39%, lymphocytes 52%, mono-
ytes 5% and eosinophils 4%), platelets 300,000/mm3, urea
0 mg/dL (normal range 10-50), creatinine 0.53 mg/dL (normal
ange 0.32-0.60), C-reactive protein (CRP) 1.1 mg/dL (normal <
), erythrocyte sedimentation rate (ESR) 7 mm/1st hour (nor-
al  range 0-20) and activated partial thromboplastin time
7.2 s, International Normalized Ratio (INR) 1.1. Homocys-
eine levels were 5.5 micromol/L (normal range 5-15), total
holesterol 176 mg/dL (normal < 200), low-density lipoproteinBY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
cholesterol 112 mg/dL (normal < 100), high-density lipopro-
tein cholesterol 49 mg/dL (normal > 40) and triglycerides
79 mg/dL (normal < 150). Brain magnetic resonance imaging
(MRI) showed ischemic areas in the right middle cerebral
artery territory, characterized by subcortical foci of restricted
diffusion in the nucleocapsular region, whereas carotid
and vertebral magnetic resonance angiography, conventional
angiography and carotid Doppler ultrasound were unremark-
able, as well as cerebrospinal ﬂuid analysis. Immunological
tests were positive for antinuclear antibodies (ANA) 1:80
(ﬁne dense speckled pattern) and negative for other serum
antibodies: anti-double stranded DNA (anti-dsDNA), anti-Sm,
anti-RNP, anti-Ro, anti-La, anticardiolipin IgM, anticardiolipin
IgG, lupus anticoagulant, anti-2-glycoprotein-1 and antineu-
trophil cytoplasmic antibodies. Urinalysis was normal, and
blood culture was negative. Protein C (115%), protein S
(126%) and factor VIII (87%) activities were within the nor-
mal  range. Factor V Leiden mutation and prothrombin gene
polymorphism were both absent. Aspirin (5.0 mg/kg/day) was
introduced, and after 4 months of rehabilitation physiother-
apy, complete recovery of the motor deﬁcits was achieved
and aspirin was withdrawn. At the age of 7 years and 8
months, he returned asymptomatic in an outpatient visit,
bringing a new brain MRI  that revealed encephalomala-
cia in the right nucleocapsular region and leptomeningeal
enhancement in the left precentral sulcus, left central sulcus,
right occipital sulcus, sphenoid portion of the right Sylvian
ﬁssure and inferior aspect of the cerebellar hemispheres, com-
patible with CNS angiitis (Fig. 1). Prophylactic aspirin was
reintroduced, and he was referred to our University Hospi-
tal. At that moment, the patient did not have complaints.
He had normal weight and height development. Peripheral
artery pulses were palpable, there was no claudication of
extremities, and blood pressure was 99 × 65 mmHg, without
differences in the limbs. No right-left shunt was observed dur-
ing echocardiography with microbubbles, CRP was 0.9 mg/dL,
and ESR was 11 mm/1st hour. At the age of 7 years and 10
months, he had a sudden and severe headache, vomiting
and reduction in consciousness level (Glasgow coma scale 7),
requiring prompt tracheal intubation. Urgent brain computed
tomography demonstrated intraparenchymal hematoma in
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Figure 1 – MRI  showing gliosis (A), paramagnetic contrast enhancement in the leptomeningeal compartment (left precentral
sulcus, left central sulcus, right occipital sulcus – B and C) and hyperintense lesions involving inferior aspect of the
cerebellar hemispheres (D).
the right parieto-occipital lobe (Fig. 2) and a small focus
of bleeding in the right front lobe, vasogenic edema, uncal
herniation and a 10 mm deviation from the midline to the
left. Decompressive craniotomy was promptly performed,
and cerebral specimen was obtained for histopathological
study. Methylprednisolone pulse therapy for three consecutive
days (1.0 g/day) was administered, followed by cyclophos-
phamide 500 mg/m2 of body surface. Laboratory tests showed
hemoglobin 13.1 g/L, hematocrit 39.7%, white blood cell count
23,300/mm3 (neutrophils 88%, lymphocytes 5%, monocytes 6%
and 1% eosinophils), platelets 352,000/mm3, urea 23 mg/dL,
creatinine 0.37 mg/dL, ESR 8 mm/1st hour, activated partial
thromboplastin time 0.91 s, and INR was 1.27. The CRP was ele-
vated (9.2 mg/dL), and vWF  antigen was 202% (normal range
50-160%). New immunological tests for detection of anticardi-
olipin IgM, anticardiolipin IgG and lupus anticoagulant were
persistently negative in three occasions. Biopsy revealed large
quantity of blood clots containing several fragments of cere-
bral tissue with gliosis, with no evidence of active vasculitis.
After a week of hospitalization, he still had left hemiparesis,
but no other sequelae; he was discharged with prednisone2 mg/kg/day. One month after the neurosurgery, prednisone
was tapered to 1.5 mg/kg/day, and a new dose of cyclophos-
phamide 500 mg/m2 was administered. The vWF  antigen was
108%, and ESR, 5 mm/1st hour. Importantly, motor deﬁcits are
progressively improving, with very light left hemiparesis and
left hemianopsia, without apparent cognitive dysfunction.
Discussion
We describe herein a case of cPACNS that presented hemor-
rhagic event with a favorable outcome after prompt drainage
and immunosuppressive therapy. The association of cPACNS
and hemorrhagic stroke has been reported only in seven cases
in the literature, mostly with poor outcome associated with
death or severe disabilities.1,4–8
cPACNS shows inﬂammation only in CNS vessels, without
involvement of other organs and systems. Moreover, this ill-
ness is not associated with secondary CNS vasculitis, caused
by infection, other inﬂammatory diseases, vascular, metabolic
and neoplastic etiologies.
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Of note, cPACNS is diagnosed according to Calabrese crite-
ia: acquired unexplained neuropsychiatric deﬁcit, classic
ngiographic or histopathologic features of CNS angiitis and
o evidence of systemic vasculitis.3 Recently, it has been
roposed two clinical subdivisions for this disorder: small ves-
el vasculitis (SV-cPACNS) or angiography-negative cPACNS
nd large and medium-sized vessel vasculitis, also known as
ngiography-positive cPACNS.2
Approximately 30% of biopsies performed in children with
uspected SV-cPACNS were negative.2 The ﬁrst choice to brain
iopsy in this population is in non-dominant frontal lobe. The
bsence of vasculitis observed in the histologic ﬁndings of our
atient might be explained by a sample of inadequate loca-
ion at the edge of the hematoma with consequent gliosis
redominance, probably due to the emergency neurosurgical
rocedure.
MRI  is an available tool to identify lesions of active SV-
PACNS.2 Although there is no pathognomonic radiologic
nding, patients with angiography-negative c-PACNS usually
xhibit multifocal lesions affecting more  than one cerebral
essel territory.9 Indeed, Benseler et al. reported four cases
f biopsy-conﬁrmed SV c-PACNS and all of the patients had
ultifocal injuries involving both gray and white matter,9 sim-
larly as observed in the present case.
Regarding clinical manifestations, SV-cPACNS has been
eported with seizures, cognitive dysfunction, headaches and
arely with intracranial hemorrhage.10 Large- and medium-
ized vessels subtype shows predominantly motor deﬁcits and
peech changes, and positive angiography is the fundamental
ool for its classiﬁcation.10 6;5 6(4):366–370 369
Interestingly, the inﬂammatory markers, such as CRP and
ESR, may help to assess disease activity, although these exams
may oscillate during the disease course. The vWF  antigen
has been described as a reliable biomarker for patients with
active systemic vasculitis. It is a plasma protein synthe-
sized by megakaryocytic and an endothelial cell that reaches
higher levels in the presence of damaged or inﬂamed vas-
cular endothelium.2,11 Moreover, increased levels of vWF
antigen were reported in 65% of c-PACNS population. Remark-
ably, these levels decreased signiﬁcantly after treatment, as
observed herein.11
Additional detections of antiphospholipid antibodies were
prospectively collected, since these antibodies may ﬂuctuate
during the disease course, reaching non-detectable levels at
the acute vascular events.12
The early neurosurgical treatment in conjunction with
immunosuppressant provided favorable outcome for our
patient. Indeed, the therapy for SV-cPACNS includes induction
with glucocorticoids and intravenous cyclophosphamide dur-
ing the ﬁrst six months and subsequent maintenance therapy
with mycophenolate mofetil for 18 months.2,3
In conclusion, we reported a favorable prognosis in a
SV-cPACNS patient with brain hemorrhage, reinforcing the
inclusion of these vasculitis as a differential diagnosis in chil-
dren and adolescents with CNS hemorrhage.
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